5 KEYS TO TREATMENT SUCCESS: YOU CAN HAVE SUCCESS WITH YOUR ALLERGIC PATIENTS BY PAYING ATTENTION TO THESE 5 STEPS FIONA BATEMAN, BVSc, MANZCVS, DACVD (continued)
Remember to set realistic expectations from the first visit – what diagnoses you are considering, how you will achieve that diagnosis and the time and commitment needed to get there. Finally, remember that allergies are a complex and ever-changing condition – you will not be able to control all the symptoms all of the time. Aim for good control for the majority of the pet’s life – and whilst flares in allergy can and will happen, have a proactive plan in place to identify and treat flares when they occur. Finally, make open and 2-way communication a goal for every itchy dog visit. This will certainly make managing allergic patients much more enjoyable (and effective) for owners and veterinary staff alike. IMPORTANT SAFETY INFORMATION FOR APOQUEL Do not use APOQUEL in dogs less than 12 months of age or those with serious infections. APOQUEL may increase the chances of developing serious infections and may cause existing parasitic skin infestations or pre-existing cancers to get worse. APOQUEL has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporine. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. APOQUEL has been used safely with many common medications including parasiticides, antibiotics and vaccines. See full Prescribing Information on the next page. CYTOPOINT has been shown to be effective for the treatment of dogs against allergic dermatitis and atopic dermatitis. LEARN MORE
REFERENCES 1. https://blog.nationwide.com/news/common-medical-conditions-for-dogs-and-cats-can-lead-to- costly-veterinary-visits/ Accessed Nov 12th, 2020. 2. Gedon NKY, Mueller RS. Atopic dermatitis in cats and dogs: a difficult disease for animals and owners. Clin Transl Allergy . 2018;8:41. 3. Sousa CA. Glucocorticoids in veterinary dermatology. In: Bonagura JD, Twedt DC, eds. Kirk’s Current Veterinary Therapy. 14th ed. St Louis, MO: Saunders Elsevier; 2009:400-404. 4. Notari L, Burman O, Mills D. Behavioural changes in dogs treated with corticosteroids. Physiol Behav. 2015;151:609-616. 5. Olivry T, DeBoer DJ, Favrot C, et al. Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA). BMC Vet Res . 2015;11:210. 6. Gonzales AJ, Bowman JW, Fici G, et al. Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. J Vet Pharmacol Ther . 2014;37(4):317- 324. doi:10.1111/jkm.12101. 7. Data on file. Study Report No. C166R-US-17-180, 2018, Zoetis Inc. 8. Souza CP, Rosychuk RAW, Contreras ET, et al. A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA. Vet Dermatol . 2018;29(6):489-e164. doi:10.1111/ vde.12682. 9. Robson D. Review of the properties and mechanisms of action of cyclosporine with an emphasis on dermatological therapy in dogs, cats and people. Vet Rec . 2003;152:768-772.
16
vetgirlontherun.com
Made with FlippingBook - Online Brochure Maker